Karyopharm Therapeutics
KPTI
KPTI
139 hedge funds and large institutions have $499M invested in Karyopharm Therapeutics in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
-4
Holders Change %
-2.8%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
26
Increased
42
Reduced
46
Closed
28
Calls
$12M
Puts
$4.09M
Net Calls
+$7.88M
Net Calls Change
+$13.6M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$40.2M |
| 2 |
CC
Commodore Capital
New York
|
+$26.2M |
| 3 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$14.7M |
| 4 |
Morgan Stanley
New York
|
+$12.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.35M |
